Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Sleeve gastrectomy, antiobesity drugs underutilized

Publish date:: May 12, 2020

Key clinical point: Despite an increasing rate of obesity in the United States, sleeve gastrectomy and postoperative antiobesity pharmacotherapy remain significantly underutilized.

Major finding: Out of the 2,717,000 adults with obesity, 25,540 (0.94%) underwent sleeve gastrectomy.

Study details: A retrospective analysis of 9,848,700 adults with obesity between 2009 and 2018.

Disclosures: Dr. Smith disclosed a relationship with US Endoscopy.

Citation:

Shah R et al. DDW 2020, Abstract 791.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Obesity

Endoscopic intragastric balloon improved NASH parameters,

Autologous fecal microbiota transplantation helped maintain weight loss after ‘green’ Mediterranean diet,

Obesity phenotyping matches patients with more effective interventions,

Bariatric surgery linked to longer life,

Psychosocial resilience associated with better cardiovascular health in Blacks,